Viewing Study NCT05328557


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-02-21 @ 9:24 PM
Study NCT ID: NCT05328557
Status: COMPLETED
Last Update Posted: 2025-02-20
First Post: 2022-03-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers
Sponsor: Cugene Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module